Comparison of Patient Satisfaction With Home Induction and In-patient Induction.
1 other identifier
observational
187
1 country
1
Brief Summary
Induced labour is a medical intervention designed to initiate or accelerate the childbirth process when clinically indicated. Induced labour concerns 25.8% of pregnant women in France, according to the latest National Perinatal Survey 2021. This rate is rising steadily, since in 2016 induction concerned 22% of pregnancies. There are many medical indications for induction, both maternal and foetal. Induced labour in hospitals is beginning to reach its limits, given the reduction in the number of nursing staff and the reduction in the number of beds available. In some cases, patients are hospitalised for 24 to 72 hours before going into labour. In this context, the place where the birth takes place, whether at home or in hospital, is essential, with a potential impact on patient satisfaction and the experience of induction. Cervical ripening can be a difficult experience for women, with a feeling of loss of control at this crucial stage. The duration of induction is one of the factors that women would like to see changed when asked about the aftermath of induction. The option of inducing at home might seem to improve women's experience and reduce the length of their stay in hospital.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Nov 2023
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 20, 2023
CompletedFirst Submitted
Initial submission to the registry
January 15, 2024
CompletedFirst Posted
Study publicly available on registry
February 22, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2024
CompletedJuly 16, 2024
July 1, 2024
7 months
January 15, 2024
July 15, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Questionnaire on patients' experience of induction in hospital and at home.
To compare patients' experiences of their induction in hospital or at home, using a questionnaire handed out after the birth.
Day 2
Questionnaire on patients' satisfaction of induction in hospital and at home.
To compare patients' satisfaction of their induction in hospital or at home, using a questionnaire handed out after the birth.
Day 2
Secondary Outcomes (6)
Questionnaire on patients' choice of induction method
Day 0
Questionnaire on reasons for choosing home induction.
Day 0
Maternal morbidity
Day 3
Maternal mortality
Day 3
Neonatal morbidity
Day 3
- +1 more secondary outcomes
Study Arms (1)
Pregnant women with induction indication
Any pregnant woman, with a singleton pregnancy, giving birth at Saint-Etienne University Hospital, with an indication for induction of labour from 37SA will be included. The indications may be for a maternal pathology, a maternal wish or a foetal pathology.
Interventions
Details of the information previously sought in the patient's file : age profession gender/parity physiological or pathological pregnancy indication for induction of labour gestational age at time of induction
Data on maternal and foetal morbidity and mortality following childbirth will be collected.
Given on arrival at the maternity unit to begin induction.
Given post-partum in the maternity unit.
Eligibility Criteria
Any pregnant woman with a singleton pregnancy, giving birth at the Saint-Etienne University Hospital, with an indication for induction of labour from 37SA. The indications could be for a maternal pathology, a maternal wish or a foetal pathology.
You may qualify if:
- Adult patient
- Singleton pregnancy
- Indication for induction of labour ≥ 37SA+0d
- Unfavourable cervix (Bishop\<6)
- Living less than 30 minutes' drive from hospital
- Having a relative at her side for a return home
You may not qualify if:
- Scarred uterus : previous caesarean section or myomectomy
- Premature rupture of membranes
- Fetal death in utero
- Placenta previa/accreta/percreta
- Severe maternal pathology : decompensated respiratory, cardiac, hepatic, renal, digestive or psychiatric disease, severe pre-eclampsia, severe growth retardation or anamnios
- Patient under guardianship, curatorship or safeguard of justice
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Chu Saint Etienne
Saint-Etienne, 42100, France
Study Officials
- PRINCIPAL INVESTIGATOR
Tiphaine BARJAT, MD PhD
CHU SAINT-ETIENNE
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 15, 2024
First Posted
February 22, 2024
Study Start
November 20, 2023
Primary Completion
June 30, 2024
Study Completion
June 30, 2024
Last Updated
July 16, 2024
Record last verified: 2024-07
Data Sharing
- IPD Sharing
- Will not share